Age-related epigenetic drift in the pathogenesis of MDS and AML

Area of Science:

• Hematology
• Epigenetics
• Cancer Biology

Background:

• Myelodysplastic syndrome (MDS) is a clonal disorder often progressing to acute myeloid leukemia (AML).
• Pathogenesis of MDS is not fully understood, but epigenetic alterations, particularly DNA methylation changes, are implicated.
• MDS treatments often involve DNA methylation inhibitors, highlighting the role of epigenetics.

Purpose of the Study:

• To investigate DNA methylation patterns in mouse models of MDS/AML and compare them with human MDS samples.
• To understand the progression of DNA methylation abnormalities from normal bone marrow to MDS and subsequently to AML.
• To determine if MDS exhibits an accelerated aging phenotype at the epigenetic level.

Main Methods:

• Analyzed DNA methylation in bone marrow and spleen of NUP98-HOXD13 (NHD13) and RUNX1 mutant mouse models of MDS/AML.
• Utilized methylation array analysis to identify hypermethylated genes in mouse models and human MDS samples.
• Performed detailed analysis of 41 specific genes across different stages (normal, MDS, AML) in mice and humans.

Main Results:

• Significant gene hypermethylation was observed in both NHD13 (14.9%) and RUNX1 (9.6%) MDS mouse models.
• A subset of hypermethylated genes was common between mouse models and human MDS samples (32%).
• DNA methylation abnormalities progressively increased from normal to MDS (accelerated aging) and further in AML, with similar patterns observed in human samples.

Conclusions:

• Aberrant DNA methylation patterns are consistent between human and mouse MDS.
• MDS exhibits an epigenetic profile suggestive of accelerated aging.
• Understanding these DNA methylation changes may offer insights into MDS pathogenesis and treatment.